Hemoglobinopathies Market The hemoglobinopathies market is advancing rapidly, driven by gene therapy, new drugs, and rising access for trea ...

Sickle cell disease is the most common genetic blood disorder in the world, most prevalent among people of colour. On World ...

The minimum acceptable oxygen delivery and flow rates during neonatal ECMO remain to be defined. We have studied the relationship of perfusion flow rates and hemoglobin saturations to oxygen ...

The guideline comes at a time when the prevalence and impact of SCD are increasing globally, particularly in regions where ...

A Harvard Medical School director, Dr. Maureen Achebe, has said that the total cost of Sickle Cell disease across Sub-Saharan Africa may rise from $ 9.1 billion per year to $10.2 billion by 2030.

Several people are unaware they are carriers of the sickle cell trait themselves, leading to further complications ...

Madhya Pradesh is currently among the worst-affected states in India when it comes to sickle cell disease, particularly in ...

A high-throughput workflow for wide-targeted metabolomics in dried blood spots (DBS) is presented.

Anemia is a common condition and has many causes, one of which is hemolytic disease of the fetus and newborn (HDFN), a ...

The Gambia has an active association (SCAG) that has been committed to the fight against sickle cell disease for over 15 years. It carries out awareness campaigns, organizes screening initiatives, and ...

As the global community commemorates World Sickle Cell Day today, the spotlight turns to Nigeria-a nation bearing one of the heaviest burdens of Sickle Cell Disease (SCD) worldwide.With over 150,000 ...